FURTHER VALIDATION OF FETAX - EVALUATION OF THE DEVELOPMENTAL TOXICITY OF 5 KNOWN MAMMALIAN TERATOGENS AND NON-TERATOGENS
FURTHER VALIDATION OF FETAX - EVALUATION OF THE DEVELOPMENTAL TOXICITY OF 5 KNOWN MAMMALIAN TERATOGENS AND NON-TERATOGENS
复制标题
DOI:
10.3109/01480549009032286
复制
发表时间:
1990-01-01
影响因子:
2.6
通讯作者:
BUSH, SJ
中科院分区:
文献类型:
--
作者:
BANTLE, JA;FORT, DJ;BUSH, SJ
The developmental toxicity of five compounds was evaluated with the Frog Embryo Teratogenesis Assay: Xenopus (FETAX). Late Xenopus laevis blastulae were exposed to 5-azacytidine, methotrexate, pseudoephedrine, aspartame, and amaranth for 96 h. Three separate static-renewal assays were conducted for each compound. Based on Teratogenic Index [LC50/EC50 (malformation)] values, types and severity of induced malformations, and embryo growth, 5-azacytidine and methotrexate tested as having strong teratogenic potential. Pseudoephedrine scored as having moderate teratogenic potential, but amaranth and aspartame had little or no teratogenic potential. Results support the use of FETAX for the screening of devleopmental toxicants.